The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.65
Low: 0.65
Prev. Close: 0.65
KZG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exclusive Tantalum Off-Take Agreement

7 Sep 2021 07:00

RNS Number : 8883K
Kazera Global PLC
07 September 2021
 

Kazera Global plc

Exclusive Tantalum Off-Take Agreement

Kazera Global plc, the AIM quoted investment company, is pleased to report that, following the conclusion of its plan to commence Tantalum production at its mine in Tantalite Valley, as announced on 1 September 2021, it has now entered into an Off-Take Agreement for the sale of all Tantalum produced by it.

 

· 3-year contract, through to 31 December 2024, entered with Jiujiang Jinxin Nonferrous Metals Co Ltd at Tantalite Valley

· A test sample assay has already been approved by the customer and airfreighted to China for factory testing

· Interest expressed in developing the Company's Lithium deposit

Utilizing Kazera Global's CEO, Larry Johnson's former long career in Tantalum supply chains, the Company entered into negotiations with several potential end users of Tantalum. After extensive due diligence, Jiujiang Jinxin Nonferrous Metals Co Ltd based in Jiangxi Province, China, was selected as the Company's preferred purchaser. Jinxin specializes in various product lines related to Tantalum, Niobium and their derived products, which include High-purity Tantalum Pentoxide, High-purity Niobium Pentoxide, Common Grade Tantalum Pentoxide, Common Grade Niobium Pentoxide and K2TaF7 (Ksalt). Jinxin ′s products are sold throughout China as well as to America, Japan, Korea and European countries. Jinxin have entered into a three-year initial contract to purchase all Tantalum concentrate produced by Kazera at a fixed price that is competitive in terms of those paid globally by end-users of Tantalum.

A test sample has already been successfully assayed in Namibia and has now been airfreighted to Jinxin for factory testing. Payment for this sample is expected by the Company during September 2021.

Jinxin has also expressed an interest in becoming involved in the Company's development of its Lithium deposit.

Larry Johnson, Kazera Joint Chief Executive Officer, commented: 

"We chose to enter into an agreement with Jinxin because they clearly understand the complexities of plant operational restarts and can utilise the high grade of Tantalite. I have also had extensive positive experience of working with them in the past. Sourcing product from Namibia has major advantages for buyers as the country is far removed from conflict and has excellent infrastructure. We were approached by dealers in Tantalum who would have accepted much lower standards, but who we felt have less growth, flexibility and commitment than displayed by Jinxin."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR').

For further information on the Company, visit: www.kazeraglobal.com

 

Kazera Global plc (c/o Camarco)

Larry Johnson/Dennis Edmonds (Joint CEO's)

Tel: +44 (0)203 757 4980

 

finnCap (Nominated Adviser and Joint Broker)

Christopher Raggett / Charlie Beeson (corporate finance)

 

Tel: +44 (0)207 220 0500

 

Camarco (PR)

Gordon Poole / James Crothers / Hugo Liddy

 

 

  Tel: +44 (0)20 3781 8331

 

**ENDS**

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREQLFBFKLLBBV
Date   Source Headline
27th Mar 20247:00 amRNSInterim Results
5th Mar 202412:44 pmRNSChange Of Registered Office
17th Jan 20245:16 pmRNSResult of AGM
4th Jan 20247:00 amRNSHolding(s) in Company
22nd Dec 20231:01 pmRNSHolding(s) in Company
22nd Dec 20231:00 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSFinal Results, Annual Report & Notice of AGM
14th Dec 20237:00 amRNSStrategic Shareholder Update
13th Dec 20233:03 pmRNSHolding(s) in Company
8th Dec 20231:02 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDiamond Project Update
6th Oct 20237:00 amRNSHeavy Minerals Sands Project Update
5th Oct 20237:00 amRNSHolding(s) in Company
13th Sep 202310:53 amRNSHolding(s) in Company
21st Jul 202312:28 pmRNSHolding(s) in Company
20th Jul 20238:45 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSReceipt Of Further Aftan Payment
5th Jul 20237:00 amRNSCorporate And Operational Update
29th Jun 20232:00 pmRNSHolding(s) in Company
29th Jun 20232:00 pmRNSHolding(s) in Company
31st May 20237:00 amRNSHolding(s) in Company
16th May 20237:00 amRNSGrant Of Options
11th May 20239:16 amRNSHolding(s) in Company
26th Apr 20231:51 pmRNSResult of AGM
20th Apr 202312:12 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSBoard Appointment
11th Apr 20237:00 amRNSInvestor Presentation
29th Mar 20239:50 amRNSHolding(s) in Company
29th Mar 20237:00 amRNSInterim Results
28th Mar 20233:00 pmRNSHolding(s) in Company
24th Mar 20239:27 amRNSHolding(s) in Company
16th Mar 20237:30 amRNSRestoration - Kazera Global plc
16th Mar 20237:00 amRNSFY2022 Results, Corporate Update & AGM Notice
10th Mar 20237:00 amRNSHolding(s) in Company
1st Mar 202312:49 pmRNSResignation of Executive Director
28th Feb 20235:41 pmRNSDelay of Results & Trading Update
9th Jan 20237:00 amRNSReceipt of further payment
3rd Jan 20237:30 amRNSSuspension - Kazera Global plc
30th Dec 202212:05 pmRNSReceipt of payment
29th Dec 20227:00 amRNSDelay of Results and Trading Update
20th Dec 20221:02 pmRNS100% disposal of African Tantalum Limited -REPLACE
20th Dec 20227:00 amRNS100% disposal of African Tantalum Limited
24th Nov 20223:31 pmRNSHolding(s) in Company
17th Oct 202211:55 amRNSHolding(s) in Company
17th Oct 20227:00 amRNSUpate Corporate Presentation
17th Oct 20227:00 amRNSUpdated Corporate Presentation
4th Oct 20227:00 amRNSAlign Research Coverage
20th Sep 20227:00 amRNSGrant of Options
31st Aug 20227:00 amRNSWalviskop Mining Permit granted
17th Aug 20227:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.